OCT 04, 2016 10:12 AM PDT

More Evidence that Cancer is Not a Matter of Bad Luck

WRITTEN BY: Xuan Pham

A controversial study last year rocked the foundation of cancer and health research, suggesting that cancer was merely just “bad luck.” Many people didn’t take keen to this notion that the fate of their health was seemingly out of their control. However, a new study challenges the claim of luck, giving hope that our cancer risks can be up to us to decide.

Image credit: Pixabay.comCancer is not the result of one singular mutation. Rather, it is a series of mutations that compound on one another in the worst possible way to derail normal biological processes. But where do the mutations come from in the first place?

As cells grow and divide, they make mistakes along the way. Most of the time, cells have extraordinary quality control measures that catch and correct these errors. In cases where the mistake is too great, the cell can self-destruct in order to prevent the mutations from carrying on to future generations. However, the proof-reading and error-checking is not perfect, not 100 percent. This is why we have such a diverse human population of varying traits, including risks for certain diseases like cancer.

If a mutation in a germ cell (that is, sperm or egg) gets through the cell’s quality control check, it will be inherited by the parent’s children. Still, other mutations are influenced by environmental and lifestyle exposures, such as smoking. But where is the line between random accidents and deliberate cause-and-effect?

The answer, according to a study published in early 2015, was that some organs’ propensity for cancer are simply due to “bad luck.” Published in Science, the study claimed that a significant portion of cancer types, including ovarian and pancreatic cancers, were due to accidental mutations in adult stem cells.

But do these “bad luck” mutations happen at a high enough rate to account for these cancer developments? A new study disputes this apparent claim.

The study, published in Nature, analyzed adult stem cells taken from various organs. The aim was to calculate the rate and patterns of DNA mutations that could account for the high cancer rates in these organs.

What they found was a steady rate of accumulation for DNA mutations, at an average of 40 mutations per year. "We were surprised to find roughly the same mutation rate in stem cells from organs with different cancer incidence," said Ruben van Boxtel, professor at the Department of Genetics at University Medical Center Utrecht in the Netherlands, and senior author of the study.
 


"This suggests that simply the gradual accumulation of more and more 'bad luck' DNA errors over time cannot explain the difference we see in cancer incidence - at least for some cancers,” he added.
So, it’s not a matter of throwing our hands in the air in regards to cancer risks. Lifestyle choices play a huge role in mutations. This isn’t to say that “bad luck” is not part of the story, it just may not play as big a role as previously thought.

"This new research by Dr. van Boxtel and his group is important because it provides actual measured data on the rate of DNA error accumulation in human stem cells for the first time, and shows that perhaps not as much cancer risk is down to this type of 'bad luck' process as has recently been suggested,” said Lara Bennet, science communication manager at Worldwide Cancer Research.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 23, 2019
Cancer
NOV 23, 2019
Anal cancer rates increase twofold
Anal cancer has been on the rise in the United States, and while it may not garner as much attention as other cancers, mortality rates for anal cancer have...
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
JAN 02, 2020
Cancer
JAN 02, 2020
The new "tumor-on-a-chip"
In order to mimic the microenvironment of a tumor in the human body, researchers from Kyoto University have developed a device that they are describing as ...
JAN 21, 2020
Cell & Molecular Biology
JAN 21, 2020
Repurposing Existing Drugs to Treat Cancer
Drugs have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for a medication....
JAN 23, 2020
Cancer
JAN 23, 2020
The role of circular RNA in melanoma
New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive c...
FEB 12, 2020
Cancer
FEB 12, 2020
Can we eradicate cervical cancer within a century?
Two studies recently published in The Lancet present evidence that the eradication of cervical cancer could be possible within the next century. The World ...
Loading Comments...